Golodirsen: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 April 2025

  • curprev 12:2912:29, 13 April 2025 Omid Afkhami-Ardakani talk contribs 4,122 bytes +4,122 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Golodirsen |aOrAn=an |drugClass=Antisense oligonucleotide​ |indicationType=treatment |indication=Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. |adverseReactions=Common Adverse Reactions (≥20% incidence): Headache, fever, fall, abdominal pain, nasopharyngitis, cough, vomiting, and nausea. |blackBoxWarningTitle=''..."